Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.
Blood
; 135(11): 862-865, 2020 03 12.
Article
in En
| MEDLINE
| ID: mdl-31961918
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Immunotherapy, Adoptive
/
Lymphoma, B-Cell
/
Antigens, CD19
/
Antigens, Neoplasm
Limits:
Adult
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2020
Document type:
Article